Journal Title:Colorectal Cancer
The Journal of Colorectal Cancer is an academic journal dedicated to the field of colorectal cancer research, covering various aspects of colorectal cancer, including etiology, pathogenesis, diagnosis, treatment, and prevention. This magazine provides a platform for medical researchers, clinical doctors, and healthcare professionals worldwide to share and exchange the latest research findings. The magazine also focuses on the prevention of colorectal cancer, emphasizing the reduction of incidence rate and mortality through screening, early diagnosis and lifestyle improvement. In addition, the magazine also discusses genetic factors, dietary habits, and other risk factors that may be associated with the occurrence of colorectal cancer.
Colorectal cancer, as the third most common cancer and the second deadliest cancer worldwide, poses a significant challenge to the health systems of many countries. Early diagnosis is crucial for reducing the mortality rate of colorectal cancer, as clinical symptoms often occur in the late stages of the disease. In addition to traditional colonoscopy, emerging minimally invasive methods such as liquid biopsy have also received widespread attention. The traditional methods for treating colorectal cancer include surgery, radiation therapy, and chemotherapy, but due to high mortality rates and disease recurrence issues, people are exploring new treatment methods such as targeted therapy, immunotherapy, and nanomedicine, some of which have entered the market and shown good results in clinical trials.
《結直腸癌雜志》是一本專注于結直腸癌研究領域的學術期刊,它涵蓋了結直腸癌的各個方面,包括病因、發病機制、診斷、治療以及預防等。該雜志為全球的醫學研究人員、臨床醫生、醫療保健專業人員提供了一個分享和交流最新研究成果的平臺。雜志還關注結直腸癌的預防,強調通過篩查、早期診斷和改善生活方式等措施來降低發病率和死亡率。此外,雜志也討論了遺傳因素、飲食習慣和其他可能與結直腸癌發生有關的風險因素。
結直腸癌作為全球第三大常見癌癥和第二大致命癌癥,對許多國家衛生系統構成了重大挑戰。早期診斷對于降低結直腸癌的死亡率至關重要,因為臨床癥狀多出現在疾病晚期。除了傳統的結腸鏡檢查,新興的微創方法如液體活檢也受到了廣泛關注。治療結直腸癌的傳統方法包括手術、放療和化療,但由于高死亡率和疾病復發問題,人們正在探索新的治療方法,例如靶向治療、免疫治療和納米醫學等,其中一些已經進入市場,并在臨床試驗中顯示出良好的結果。
Colorectal Cancer收稿方向涵蓋ONCOLOGY全領域,平均審稿速度 ,影響因子指數2.7,該期刊近期沒有被列入國際期刊預警名單,廣大學者值得一試。
| 按JIF指標學科分區 | 收錄子集 | 分區 | 排名 | 百分位 |
| 學科:ONCOLOGY | ESCI | Q3 | 163 / 322 |
49.5% |
| 按JCI指標學科分區 | 收錄子集 | 分區 | 排名 | 百分位 |
| 學科:ONCOLOGY | ESCI | Q4 | 285 / 322 |
11.65% |
名詞解釋:
WOS即Web of Science,是全球獲取學術信息的重要數據庫,Web of Science包括自然科學、社會科學、藝術與人文領域的信息,來自全世界近9,000種最負盛名的高影響力研究期刊及12,000多種學術會議多學科內容。給期刊分區時會按照某一個學科領域劃分,根據這一學科所有按照影響因子數值降序排名,然后平均分成4等份,期刊影響因子值高的就會在高分區中,最后的劃分結果分別是Q1,Q2,Q3,Q4,Q1代表質量最高。
| 是否OA開放訪問: | h-index: | 年文章數: |
| 未開放 | - | 4 |
| Gold OA文章占比: | 2021-2022最新影響因子(數據來源于搜索引擎): | 開源占比(OA被引用占比): |
| 71.43% | 2.7 | |
| 研究類文章占比:文章 ÷(文章 + 綜述) | 期刊收錄: | 中科院《國際期刊預警名單(試行)》名單: |
| 75.00% | SCIE | 否 |
歷年IF值(影響因子):
歷年引文指標和發文量:
歷年自引數據:
若用戶需要出版服務,請聯系出版商。